US Patent Issued to Purdue Research Foundation on Dec. 2 for "Cholecystokinin B receptor targeting for imaging and therapy" (Indiana Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,179, issued on Dec. 2, was assigned to Purdue Research Foundation (West Lafayette, Ind.).

"Cholecystokinin B receptor targeting for imaging and therapy" was invented by Philip Stewart Low (West Lafayette, Ind.) and Charity Wayua (West Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Conjugates are described herein where CCK2R targeting ligands are attached to an active moiety, such as therapeutic agent or an imaging agent, through a linker. The conjugates can be used in the detection, diagnosis, imaging and treatment of cancer."

The patent was filed on May 9, 2022, under Application No. 17/739,873.

*For further information, including ...